Log In
Print this Print this

Colobreathe, colistimethate sodium

Also known as: colomycin

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionInhaled polymyxin antibiotic
Molecular Target Lipopolysaccharide (LPS)
Mechanism of ActionCell membrane integrity disruption
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRespiratory infection
Indication DetailsTreat cystic fibrosis (CF) patients infected with Pseudomonas aeruginosa; Treat cystic fibrosis (CF) patients with lung infection
Regulatory Designation EU - Orphan Drug (Treat cystic fibrosis (CF) patients infected with Pseudomonas aeruginosa)
Partnermoksha8 Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today